Statera Biopharma, Inc.
STAB
$0.0001
$0.000.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -29.40% | 116.85% | -83.30% | -79.06% | -31.41% |
| Total Receivables | -12.87% | 46.26% | -18.69% | 141.89% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -60.53% | -50.58% | -49.10% | -63.48% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -13.92% | -10.37% | -60.66% | -19.11% | 109.74% |
| Total Current Assets | -27.14% | 15.91% | -65.19% | -68.82% | 337.46% |
|
|
|||||
| Total Current Assets | -27.14% | 15.91% | -65.19% | -68.82% | 337.46% |
| Net Property, Plant & Equipment | -18.02% | -6.31% | 13.94% | 21.52% | 19,094.00% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | -87.96% | -- |
| Goodwill | 0.00% | 0.00% | 0.00% | -87.96% | -- |
| Total Other Intangibles | -8.40% | -7.75% | -7.19% | 0.36% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -3.85% | -51.75% |
| Total Assets | -5.86% | 0.24% | -36.18% | -78.41% | 608.93% |
|
|
|||||
| Total Accounts Payable | 0.75% | 19.68% | 70.10% | 24.34% | 5,170.74% |
| Total Accrued Expenses | 74.98% | 133.05% | -11.62% | -2.41% | 647.31% |
| Short-term Debt | 0.00% | 8.48% | 28.89% | 48.38% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -11.29% | 3.23% | 38.59% | 28.59% | -- |
| Total Finance Division Other Current Liabilities | -13.17% | 131.58% | -23.98% | -63.62% | -- |
| Total Other Current Liabilities | -13.17% | 131.58% | -23.98% | -63.62% | -- |
| Total Current Liabilities | 13.02% | 30.50% | 34.04% | 10.38% | 3,289.02% |
|
|
|||||
| Total Current Liabilities | 13.02% | 30.50% | 34.04% | 10.38% | 3,289.02% |
| Long-Term Debt | -- | -- | -- | -17.74% | -- |
| Short-term Debt | 0.00% | 8.48% | 28.89% | 48.38% | -- |
| Capital Leases | -13.51% | -8.95% | 8.09% | 9.32% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 11.99% | 28.34% | -29.69% | -4.89% | 7,831.27% |
|
|
|||||
| Common Stock & APIC | 0.05% | -0.79% | 5.36% | 1.22% | 1,374.77% |
| Retained Earnings | -2.38% | -2.54% | -5.99% | -147.78% | -- |
| Treasury Stock & Other | 113.10% | 203.70% | -262.69% | -235.00% | -- |
| Total Common Equity | -46.54% | -181.23% | -58.49% | -102.12% | 764.96% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -46.54% | -181.23% | -58.49% | -102.12% | 764.96% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 8.31% | 34.53% | -18.27% | -15.10% | -98.54% |
| Total Equity | -46.91% | -184.23% | -61.61% | -102.03% | 448.45% |
|
|
|||||